Walleye Capital LLC 2seventy Bio, Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$8.45 - $12.48 $636,344 - $939,831	75,307 New	75,307 $762,000
Q4 2022 Feb 14, 2023	BUY	$8.57 - $17.0 $124,916 - $247,792	14,576 Added 90.56%	30,671 $287,000
Q3 2022 Nov 14, 2022	BUY	$12.56 - $17.54 $202,153 - $282,306	16,095 New	16,095 $234,000
Q1 2022 May 16, 2022	SELL	$11.67 - $26.72 $269,693 - $617,499	-23,110 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$13.77 - $42.56 $318,224 - $983,561	23,110 New	23,110 $592,000

126

45.6M

122K

19.8K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $137M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.